Evidence map›Paper›PMID 29281252›Full record

ArticleACS chemical neuroscience2018

Toward Serotonin Fluorescent False Neurotransmitters: Development of Fluorescent Dual Serotonin and Vesicular Monoamine Transporter Substrates for Visualizing Serotonin Neurons.

Adam Henke, Yekaterina Kovalyova, Matthew Dunn, Dominik Dreier, Niko G Gubernator, Iva Dincheva, Christopher Hwu, Peter Šebej, Mark S Ansorge, David Sulzer and 1 more

Open access · greenAbstract read
In one paragraph

Article in ACS chemical neuroscience, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Interaction of major monoterpenes fromFrontiers in pharmacology · 2026
    Article
  3. Review
  4. Article
  5. Measuring serotonin binding to its receptorsbioRxiv : the preprint server for biology · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. New optical methods for detecting monoamine neuromodulators.Current opinion in biomedical engineering · 2019
    Article
  17. Article
  18. Article
  19. Review Article: Tools and trends for probing brain neurochemistry.Journal of vacuum science & technology. A, Vacuum, surfaces, and films : an official journal of the American Vacuum Society · 2019
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Adam HenkeDepartment of Chemistry and Neuro Technology Center at Columbia University , New York , New York 10027 , United States.
Yekaterina KovalyovaDepartment of Chemistry and Neuro Technology Center at Columbia University , New York , New York 10027 , United States.
Matthew DunnDepartment of Chemistry and Neuro Technology Center at Columbia University , New York , New York 10027 , United States.ORCID 0000-0002-7015-203X
Dominik DreierDepartment of Chemistry and Neuro Technology Center at Columbia University , New York , New York 10027 , United States.
Niko G GubernatorDepartment of Chemistry and Neuro Technology Center at Columbia University , New York , New York 10027 , United States.
Iva DinchevaDepartment of Psychiatry , Columbia University , New York , New York 10032 , United States.
Christopher HwuDepartment of Chemistry and Neuro Technology Center at Columbia University , New York , New York 10027 , United States.
Peter ŠebejDepartment of Chemistry and Neuro Technology Center at Columbia University , New York , New York 10027 , United States.
Mark S AnsorgeDepartment of Psychiatry , Columbia University , New York , New York 10032 , United States.
David SulzerDepartment of Psychiatry , Columbia University , New York , New York 10032 , United States.
Dalibor SamesDepartment of Chemistry and Neuro Technology Center at Columbia University , New York , New York 10027 , United States.
Columbia University · US

Funding

The Presynaptic Vesicle Cycle for the Slow Acting Neurotransmitter SecretionP01DA010154 · NIDA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI EDWARDS, ROBERT H, KREITZER, ANATOL · 1995 to 2016
$14.7M
The Dopamine Synapse and Associative LearningR01DA007418 · NIDA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI David Sulzer · 1999 to 2026
$9.4M
Development of Fluorescent False NeurotransmittersR01MH108186 · NIMH · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI SAMES, DALIBOR, SULZER, DAVID · 2015 to 2024
$5.8M
Design of Molecular Probes For Optical Imaging of Dopamine NeurotransmissionR01MH086545 · NIMH · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI SAMES, DALIBOR · 2010 to 2013
$1.5M
Developmental Origins of Affective DisordersR00MH083044 · NIMH · NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC · PI ANSORGE, MARK SASCHA · 2010 to 2012
$736k
NIDA NIH HHS P01 DA010154NIDA NIH HHS R01 DA007418NIMH NIH HHS R00 MH083044NIMH NIH HHS R01 MH086545NIMH NIH HHS R01 MH108186
6 · The paper itself

Abstract

Ongoing efforts in our laboratories focus on design of optical reporters known as fluorescent false neurotransmitters (FFNs) that enable the visualization of uptake into, packaging within, and release from individual monoaminergic neurons and presynaptic sites in the brain. Here, we introduce the molecular probe FFN246 as an expansion of the FFN platform to the serotonergic system. Combining the acridone fluorophore with the ethylamine recognition element of serotonin, we identified FFN54 and FFN246 as substrates for both the serotonin transporter and the vesicular monoamine transporter 2 (VMAT2). A systematic structure-activity study revealed the basic structural chemotype of aminoalkyl acridones required for serotonin transporter (SERT) activity and enabled lowering the background labeling of these probes while maintaining SERT activity, which proved essential for obtaining sufficient signal in the brain tissue (FFN246). We demonstrate the utility of FFN246 for direct examination of SERT activity and SERT inhibitors in 96-well cell culture assays, as well as specific labeling of serotonergic neurons of the dorsal raphe nucleus in the living tissue of acute mouse brain slices. While we found only minor FFN246 accumulation in serotonergic axons in murine brain tissue, FFN246 effectively traces serotonin uptake and packaging in the soma of serotonergic neurons with improved photophysical properties and loading parameters compared to known serotonin-based fluorescent tracers.

Indexed as

AnimalsAxonsBrainMiceNeurotransmitter AgentsSerotonergic NeuronsSerotonin Plasma Membrane Transport ProteinsVesicular Monoamine Transport ProteinsNeurotransmitter AgentsSerotonin Plasma Membrane Transport ProteinsVesicular Monoamine Transport Proteins5-HTFFN246fluorescent false neurotransmittersimaging probemonoaminergic neuronsserotonin

Identifiers

PMID29281252
PMCPMC6342556
OpenAlexW2778170849

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.